Amira is a pharmacist who gained her PhD in the in-field detection of New Psychoactive Substance (NPS). Amira is the MPharm Programme Director at Swansea University Medical School and a Senior Fellow of the Higher Education Academy. She is the Scheduled Drugs Lead of the RPS (Royal Pharmaceutical Society) Science and Research Committee, a committee member of JPAG (Joint Pharmaceutical Analysis Group), RPS London North West, Research Strategy Implementation Group for Wales (RSIG) and a member of the RPS Medicines, Ethics and Practice advisory board. Amira’s research interests focus on enhancing the in-field detection of NPS, training and education of healthcare professionals on NPS and developing harm reduction interventions including establishing Drug Checking Services.
Apr 26, 2024 01:37 am UTC| Insights & Views Health
Vaping is now more common than cigarette smoking among young people, according to a new report coordinated by the University of Glasgow and commissioned by the World Health Organization. This echoes research that has...
Over-the-counter opioids: does Britain have a codeine problem?
Jun 15, 2023 05:39 am UTC| Insights & Views
Earlier this year, the NHS announced that it had cut opioid prescriptions by almost half a million in four years. But opioids arent just available on prescription in the UK. They can be bought over the counter at...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US student Gaza protests: five things that have been missed
Will Solomon Islands’ new leader stay close to China?
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects